Skip to main content
Top
Published in: Archives of Dermatological Research 6/2021

01-08-2021 | Metastasis | Original Paper

Metastatic head and neck cutaneous basal cell carcinomas: a retrospective observational study

Authors: Karina Furlan, Vijaya Reddy, Anas Alabkaa, Prih Rohra, Fatima Mir, Paolo Gattuso

Published in: Archives of Dermatological Research | Issue 6/2021

Login to get access

Abstract

Cutaneous basal cell carcinoma is usually an indolent and slow-growing tumor with potential for local invasion and recurrence; however, metastatic events are exceedingly rare. The annual incidence of metastasis is estimated to range between 0.00281 and 0.05%. A retrospective search in the pathology database of a single tertiary institution was performed in the period between 1999 to 2019. Primary cutaneous metastatic basal cell carcinomas had paraffin blocks and glass slides retrieved. A total of 8673 cases was identified. The overall prevalence of metastatic tumors was 0.05% (4/8673). The median patient’s age at diagnosis was 61 years old (range 52–79). The most common primary site of tumor was nose (2/4) and the most common histological subtype was infiltrative. The sampled lymph nodes were identified during primary tumor resection, except for 1 patient who had a sentinel lymph node biopsy performed as a surgeon individual decision. One patient had hematogenous spread to the pleura, diagnosed 5 years after diagnosis. In summary, this study adds new data to the current literature in metastatic primary cutaneous basal cell carcinomas and highlights the importance of early diagnosis and appropriate surgical excision in an effort to prevent local advanced disease, recurrence and lymphovascular dissemination.
Literature
1.
go back to reference Wahl RU, Cacchi C, Rübben A (2018) Cutaneous basal cell carcinoma with lymph node and pulmonary metastases. Case Rep Oncol Med. 2018:1–4 Wahl RU, Cacchi C, Rübben A (2018) Cutaneous basal cell carcinoma with lymph node and pulmonary metastases. Case Rep Oncol Med. 2018:1–4
2.
go back to reference Mohan SV, Chang ALS (2014) Advanced basal cell carcinoma: epidemiology and therapeutic innovations. Curr Dermatol Rep. 3:40–45CrossRef Mohan SV, Chang ALS (2014) Advanced basal cell carcinoma: epidemiology and therapeutic innovations. Curr Dermatol Rep. 3:40–45CrossRef
3.
go back to reference Hamid O, Goldenberg G (2013) Identifying patients at risk for recurrent or advanced BCC. J Drugs Dermatol JDD 12(11):1246–1252 quiz 1253–4PubMed Hamid O, Goldenberg G (2013) Identifying patients at risk for recurrent or advanced BCC. J Drugs Dermatol JDD 12(11):1246–1252 quiz 1253–4PubMed
4.
go back to reference Nakamura Y, Ishitsuka Y, Ohara K, Otsuka F (2012) Basal cell carcinoma on the dorsum of the foot with inguinal and pelvic lymph nodes metastases. Int J Dermatol 51(9):1068–1073CrossRef Nakamura Y, Ishitsuka Y, Ohara K, Otsuka F (2012) Basal cell carcinoma on the dorsum of the foot with inguinal and pelvic lymph nodes metastases. Int J Dermatol 51(9):1068–1073CrossRef
5.
go back to reference Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D (2017) Epidemiological trends in skin cancer. Dermatol Pract Concept 7(2):1–6CrossRef Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D (2017) Epidemiological trends in skin cancer. Dermatol Pract Concept 7(2):1–6CrossRef
6.
go back to reference Wysong A, Aasi SZ, Tang JY (2013) Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011. JAMA Dermatol 149(5):615–616CrossRef Wysong A, Aasi SZ, Tang JY (2013) Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011. JAMA Dermatol 149(5):615–616CrossRef
7.
go back to reference Bakshi A, Chaudhary SC, Rana M, Elmets CA, Athar M (2017) Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond. Mol Carcinog 56(12):2543–2557CrossRef Bakshi A, Chaudhary SC, Rana M, Elmets CA, Athar M (2017) Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond. Mol Carcinog 56(12):2543–2557CrossRef
8.
go back to reference Fram BR, Strony J, Jagannathan G, Brown SA (2019) Cutaneous basal cell carcinoma with bone metastases: an orthopaedic case report. Case Rep Orthop 2019:1628980PubMedPubMedCentral Fram BR, Strony J, Jagannathan G, Brown SA (2019) Cutaneous basal cell carcinoma with bone metastases: an orthopaedic case report. Case Rep Orthop 2019:1628980PubMedPubMedCentral
10.
go back to reference Snow SN, Sahl W, Lo JS, Mohs FE, Warner T, Dekkinga JA et al (1994) Metastatic basal cell carcinoma. Report five cases. Cancer 73(2):328–335CrossRef Snow SN, Sahl W, Lo JS, Mohs FE, Warner T, Dekkinga JA et al (1994) Metastatic basal cell carcinoma. Report five cases. Cancer 73(2):328–335CrossRef
11.
go back to reference Von Domarus H, Stevens PJ (1984) Metastatic basal cell carcinoma Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10(6):1043–1060CrossRef Von Domarus H, Stevens PJ (1984) Metastatic basal cell carcinoma Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10(6):1043–1060CrossRef
12.
go back to reference Kwon C-S, Awar OA, Ripa V, Said G, Rocka S (2018) Basal cell carcinoma of the scalp with destruction and invasion into the calvarium and dura mater: report of 7 cases and review of literature. J Clin Neurosci Off J Neurosurg Soc Austr 47:190–197 Kwon C-S, Awar OA, Ripa V, Said G, Rocka S (2018) Basal cell carcinoma of the scalp with destruction and invasion into the calvarium and dura mater: report of 7 cases and review of literature. J Clin Neurosci Off J Neurosurg Soc Austr 47:190–197
13.
go back to reference Kanzaki A, Ansai S-I, Ueno T, Kawana S, Shimizu A, Naito Z et al (2017) A case of metastatic basal cell carcinoma treated with cisplatin and adriamycin. J Nippon Med Sch Nippon Ika Daigaku Zasshi 84(6):286–290CrossRef Kanzaki A, Ansai S-I, Ueno T, Kawana S, Shimizu A, Naito Z et al (2017) A case of metastatic basal cell carcinoma treated with cisplatin and adriamycin. J Nippon Med Sch Nippon Ika Daigaku Zasshi 84(6):286–290CrossRef
14.
go back to reference Gropper AB, Girouard SD, Hojman LP, Huang SJ, Qian X, Murphy GF et al (2012) Metastatic basal cell carcinoma of the posterior neck: case report and review of the literature. J Cutan Pathol 39(5):526–534CrossRef Gropper AB, Girouard SD, Hojman LP, Huang SJ, Qian X, Murphy GF et al (2012) Metastatic basal cell carcinoma of the posterior neck: case report and review of the literature. J Cutan Pathol 39(5):526–534CrossRef
15.
go back to reference Moser S, Borm J, Mihic-Probst D, Jacobsen C, Kruse Gujer AL (2014) Metastatic basal cell carcinoma: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol 117(2):e79–e82CrossRef Moser S, Borm J, Mihic-Probst D, Jacobsen C, Kruse Gujer AL (2014) Metastatic basal cell carcinoma: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol 117(2):e79–e82CrossRef
17.
go back to reference Branson SV, McClintic E, Ozgur O, Esmaeli B, Yeatts RP (2017) Orbitofacial metastatic basal cell carcinoma: report of 10 cases. Ophthal Plast Reconstr Surg 33(3):213–217CrossRef Branson SV, McClintic E, Ozgur O, Esmaeli B, Yeatts RP (2017) Orbitofacial metastatic basal cell carcinoma: report of 10 cases. Ophthal Plast Reconstr Surg 33(3):213–217CrossRef
18.
go back to reference Siegle RJ, MacMillan J, Pollack SV (1986) Infiltrative basal cell carcinoma: a nonsclerosing subtype. J Dermatol Surg Oncol 12(8):830–836CrossRef Siegle RJ, MacMillan J, Pollack SV (1986) Infiltrative basal cell carcinoma: a nonsclerosing subtype. J Dermatol Surg Oncol 12(8):830–836CrossRef
19.
go back to reference Amram AL, Hertzing WJ, Smith SV, Chévez-Barrios P, Lee AG (2018) Perineural spread of basosquamous carcinoma to the orbit, cavernous sinus, and infratemporal fossa. Orbit Amst Neth 37(2):110–114 Amram AL, Hertzing WJ, Smith SV, Chévez-Barrios P, Lee AG (2018) Perineural spread of basosquamous carcinoma to the orbit, cavernous sinus, and infratemporal fossa. Orbit Amst Neth 37(2):110–114
20.
go back to reference Dandurand M, Petit T, Martel P, Guillot B, ANAES (2006) Management of basal cell carcinoma in adults Clinical practice guidelines. Eur J Dermatol EJD 16(4):394–401PubMed Dandurand M, Petit T, Martel P, Guillot B, ANAES (2006) Management of basal cell carcinoma in adults Clinical practice guidelines. Eur J Dermatol EJD 16(4):394–401PubMed
21.
go back to reference Garcia C, Poletti E, Crowson AN (2009) Basosquamous carcinoma. J Am Acad Dermatol 60(1):137–143CrossRef Garcia C, Poletti E, Crowson AN (2009) Basosquamous carcinoma. J Am Acad Dermatol 60(1):137–143CrossRef
22.
go back to reference Tang S, Thompson S, Smee R (2017) Metastatic basal cell carcinoma: case series and review of the literature. Austr J Dermatol 58(2):e40–e43CrossRef Tang S, Thompson S, Smee R (2017) Metastatic basal cell carcinoma: case series and review of the literature. Austr J Dermatol 58(2):e40–e43CrossRef
23.
go back to reference Foley P (2015) Current landscape for treatment of advanced basal cell carcinoma. Austr J Dermatol 56(Suppl 1):1–7CrossRef Foley P (2015) Current landscape for treatment of advanced basal cell carcinoma. Austr J Dermatol 56(Suppl 1):1–7CrossRef
24.
go back to reference Casswell G, Cavanagh K, RaviKumar AS, Giddings C, McDowell L (2019) Setting the stage: contemporary staging of non-melanomatous skin cancer and implementation of the new American Joint Committee on cancer eighth edition staging manual. Oral Oncol 98:102–108CrossRef Casswell G, Cavanagh K, RaviKumar AS, Giddings C, McDowell L (2019) Setting the stage: contemporary staging of non-melanomatous skin cancer and implementation of the new American Joint Committee on cancer eighth edition staging manual. Oral Oncol 98:102–108CrossRef
25.
go back to reference Wahid M, Jawed A, Mandal RK, Dar SA, Khan S, Akhter N et al (2016) Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas. Crit Rev Oncol Hematol 98:235–241CrossRef Wahid M, Jawed A, Mandal RK, Dar SA, Khan S, Akhter N et al (2016) Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas. Crit Rev Oncol Hematol 98:235–241CrossRef
26.
go back to reference Yin VT, Pfeiffer ML, Esmaeli B (2013) Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma. Ophthal Plast Reconstr Surg 29(2):87–92CrossRef Yin VT, Pfeiffer ML, Esmaeli B (2013) Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma. Ophthal Plast Reconstr Surg 29(2):87–92CrossRef
27.
go back to reference Peris K, Licitra L, Ascierto PA, Corvò R, Simonacci M, Picciotto F et al (2015) Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensus. Future Oncol Lond Engl 11(4):703–712CrossRef Peris K, Licitra L, Ascierto PA, Corvò R, Simonacci M, Picciotto F et al (2015) Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensus. Future Oncol Lond Engl 11(4):703–712CrossRef
Metadata
Title
Metastatic head and neck cutaneous basal cell carcinomas: a retrospective observational study
Authors
Karina Furlan
Vijaya Reddy
Anas Alabkaa
Prih Rohra
Fatima Mir
Paolo Gattuso
Publication date
01-08-2021
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 6/2021
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-020-02120-y

Other articles of this Issue 6/2021

Archives of Dermatological Research 6/2021 Go to the issue